권병세 (주식회사 유틸렉스)님 | 한빛사연구자 > 한빛사

주식회사 유틸렉스

면역의학

최종업데이트 2021.09.15.

Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rαhi CD8+ T cells
- Nat. Commun., Published 07 September 2021 | https://doi.org/10.1038/s41467-021-25559-7
- 2021-09
- 의약학
- 한빛사논문
Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
- Nat. Commun., Published online:01 February 2018, 9, Article number: 468, doi:10.1038/s41467-018-02912-x
- 2018-02
- 의약학
- 한빛사논문
Extracellular stimulation of VSIG4/complement receptor Ig suppresses intracellular bacterial infection by inducing autophagy.
- Autophagy, Published online: 20 Jul 2016 | DOI:10.1080/15548627.2016.1196314
- 2016-07
- 의약학
- 한빛사논문
4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1
- J. Immunol., 2002, 169: 4882-4888.
- 2002-11
- 의약학
- 상위피인용논문
A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis
- J. Biol. Chem., doi: 10.1074/jbc.274.20.13733
- 1999-05
- 의약학
- 상위피인용논문
Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells
- Blood, 1 March 2005, Vol. 105, No. 5, pp. 2206-2213.
- 2005-03
- 의약학
- 한빛사논문
4-1BB-mediated immunotherapy of rheumatoid arthritis
- Nat. Med., 10, 1088 - 1094 (2004)
- 2004-10
- 의약학
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기